Loading...
•
Sep 30, 2024
Integra LifeSciences Q3 2024 Earnings Report
Integra LifeSciences' Q3 2024 financial performance reflected a decrease in revenue and earnings per share compared to the prior year, while shipping holds were releasing as expected and Integra Skin production was on pace.
Key Takeaways
Integra LifeSciences reported a slight decrease in third-quarter revenue and a significant drop in GAAP and adjusted earnings per share compared to the previous year. The company is progressing with its compliance master plan and announced Mojdeh Poul as the next president and CEO.
Third quarter revenues decreased 0.4% on a reported basis and 8.6% on an organic basis.
GAAP earnings per diluted share were $(0.14), compared to $0.24 in the prior year; adjusted earnings per diluted share was $0.41, compared to $0.76 in the prior year.
Shipping holds communicated during the second quarter earnings call are releasing in line with expectations.
Integra Skin production is on pace to meet historical revenue run rates for the fourth quarter.
Revenue by Segment
Forward Guidance
For the fourth quarter 2024, the Company expects reported revenues in the range of $441 million to $451 million, representing reported growth of 11.1% to 13.6% and organic growth of 2.0% to 4.5%. The Company expects adjusted EPS in a range of $0.81 to $0.89. For the full year 2024, the Company is updating its revenue and adjusted EPS ranges of $1.609 billion to $1.619 billion and $2.41 to $2.49, respectively. The revenue range represents reported growth of 4.4% to 5.0% and organic growth of -1.7% to -1.0%.
Positive Outlook
- Integration of Acclarent.
- Stepped up revenue from progress clearing the third-quarter shipping holds.
- Improved production for Integra Skin.
Challenges Ahead
- Additional quality holds.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...